Fucosidosis

Alternative Names

  • Alpha-L-Fucosidosis Deficiency

Associated Genes

Fucosidase, Alpha-L, 1
Back to search Result
WHO-ICD-10 version:2010

Endocrine, nutritional and metabolic diseases

Metabolic disorders

OMIM Number

230000

Mode of Inheritance

Autosomal recessive

Gene Map Locus

1p36.11

Description

Fucosidosis is a rare autosomal recessive lysosomal storage disorder characterized by progressive psychomotor retardation, facial dysmorphism, deafness, angiokeratoma, neurologic signs, moderate hepatomegaly, and dysostosis multiplex. Fucosidosis has been graded into two major types, type 1 (severe) and type 2 (moderate). Age of onset for type 1 ranges between 3 and 18 months and is differentiated through rapid psychomotor regression and severe neurologic deterioration commencing 6 months of age, elevated sweat chloride, and fatality within the first decade of life. Type 2 has slower progression and is differentiated through milder psychomotor retardation and neurologic symptoms, the growth of angiokeratoma corporis diffusum, normal sweat salinity, and extended survival. Fucosidosis originates due to alpha-L-fucosidase deficiency with a buildup of fucose in body tissues. Fucosidosis is treated through allogenic bone marrow transplantation; however, fewer than 10 cases worldwide have undergone this treatment.

Fucosidosis is caused due to mutations in the fucosidase, alpha-L-1, tissue (FUCA1) gene, which encodes alpha-L-fucosidase enzyme.

Epidemiology in the Arab World

View Map
Subject IDCountrySexFamily HistoryParental ConsanguinityHPO TermsVariantZygosityMode of InheritanceReferenceRemarks
230000.1United Arab EmiratesFemaleNoYes Global developmental delay; Intellectual...NM_000147.4:c.558dupHomozygousAutosomal, RecessiveSaleh et al. 2021

Other Reports

Kuwait

Ismail et al. (1999) reported a 3.5 year old Bedouin boy who displayed clinical features of type 1 and type 2 fucosidosis. He was born at term to second-degree cousin Bedouin parents following uneventful pregnancy; he weighed 3kg and was the fifth child in a sibship of six. The boy's mother and one of his siblings were found to be asthmatic, whereas his father and other siblings were healthy. The patient suffered from bronchopneumonia at the age of 7 months and over the following three years he suffered from pulmonary infection and bronchospasm and showed negative response to bronchodilators, corticosteroids, for otitis media and periapical dental abscess. At the age of 13 months, the subject experienced mild hepatomegaly with normal echogenicity and bilateral nerve deafness of 70 dB. Meanwhile, at the age of 21 months the subjects' alpha L-fucosidase activity was assayed with fluorigenic substrate 4-methylumbellifery1-alpha-L-fucoside, the assay was negative for leucocytes in the patient and was found in both parents as 19 nmol/mg protein/h (range 30-189). The patient underwent cranial magnetic resonance imaging (MRI) at the age of 3.5 years which revealed increased signal intensity in the periventricular, supraventricular and subcortical white matter, further more in the parieto-occipital than in the frontal area and reduced signal intensity in the globus pallidus. Based on the symptoms Ismail et al. (1999) demonstrated that the subject showed the classic features of type 1 (early presentation throughout infancy and sever psychomotor retardation) and type 2 (angiokeratoma corporis diffusum and normal sweat test) fucosidosis; however, the recurrent pulmonary infections of the patient could be explained.

© CAGS 2024. All rights reserved.